摘要 |
The present invention provides a pyrazolo[1,5-a]pyrimidine compound, having CB1 receptor-antagonizing activity, of the following formula [I]: in which R<SUB>1</SUB> and R<SUB>2</SUB> are the same or different and each an optionally substituted aryl group etc, R<SUB>0</SUB> is hydrogen atom, an alkyl group etc, E is a group of the formula: -C(=O)- or -SO?2#191-, R is a group of the following formula [i], [ii] or [iii] etc: Ring A is (a) a C?3-8#191 cycloalkyl group optionally fused to a benzene ring or (b) a benzene ring, Q is a single bond or a methylene group, Ring B is a 4- to 7-membered aliphatic heterocyclic group, said cyclic group binding via its ring-carbon atom to the adjacent nitrogen atom, X is sulfur atom etc, R<SUB>3</SUB> is an alkyl group optionally substituted by an alkylthio group, R<SUB>4</SUB> is hydrogen atom, an alkyl group etc, one of R<SUB>A</SUB> and R<SUB>B</SUB> is an alkyl group etc, and the other is hydrogen atom, an alkyl group etc, or a pharmaceutically acceptable salt thereof. |
申请人 |
MITSUBISHI TANABE PHARMA CORPORATION;TANIMOTO, KOICHI;OI, MARIKO;TSUBOI, YASUNORI;MORITANI, YASUNORI |
发明人 |
TANIMOTO, KOICHI;OI, MARIKO;TSUBOI, YASUNORI;MORITANI, YASUNORI |